Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZ) Debt to Equity (2021 - 2026)

Core Scientific has reported Debt to Equity over the past 6 years, most recently at -$1.57 for Q1 2026.

  • Quarterly results put Debt to Equity at -$1.57 for Q1 2026, up 54.64% from a year ago — trailing twelve months through Mar 2026 was -$1.57 (up 54.64% YoY), and the annual figure for FY2025 was -$1.1, up 3.29%.
  • Debt to Equity reached -$1.57 in Q1 2026 per CORZ's latest filing, down from -$1.1 in the prior quarter.
  • Across five years, Debt to Equity topped out at $2.06 in Q2 2022 and bottomed at -$3.47 in Q1 2025.
  • Median Debt to Equity over the past 5 years was -$0.89 (2025), compared with a mean of -$0.76.
  • The largest annual shift saw Debt to Equity soared 2168.09% in 2022 before it plummeted 388830.33% in 2024.
  • Over 5 years, Debt to Equity stood at $0.07 in 2022, then crashed by 1682.89% to -$1.15 in 2023, then grew by 0.62% to -$1.14 in 2024, then grew by 3.29% to -$1.1 in 2025, then tumbled by 42.94% to -$1.57 in 2026.
  • Business Quant data shows Debt to Equity for CORZ at -$1.57 in Q1 2026, -$1.1 in Q4 2025, and -$0.85 in Q3 2025.